Company intelligence / Profile preview

Hunan Dongting Pharmaceutical

Changde City, Hunan, China

Ownership: Private
Development stage: Other

Overview

Hunan Dongting Pharmaceutical is a leading Chinese manufacturer of haemostatic and psychotropic drugs, with its principal products including tranexamic acid and quetiapine fumarate; these are exported worldwide, with multiple GMP and regulatory certifications, and its CNS drug preparations are distributed widely in the Chinese domestic market.

Therapeutic areas: HematologyImmunologyDermatologyPsychiatry
Modalities: Small molecule
Industry: Biotech

Partnerships

Fosun Pharma (strategic parent, R&D integration)

Beyond the preview

Go deeper on Hunan Dongting Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hunan Dongting Pharmaceutical.

Explore the full profile